Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biodelivery Sci Intl (BDSI)

4.07   -0.13 (-3.1%) 01-27 02:33
Open: 4.2 Pre. Close: 4.2
High: 4.205 Low: 4.07
Volume: 908,152 Market Cap: 412M
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.205 - 4.226 4.226 - 4.246
Low: 4.01 - 4.036 4.036 - 4.061
Close: 4.023 - 4.063 4.063 - 4.103

Technical analysis

as of: 2021-01-26 4:41:29 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.41     One year: 5.83
Support: Support1: 4.06    Support2: 3.38
Resistance: Resistance1: 4.63    Resistance2: 4.99
Pivot: 4.38
Moving Average: MA(5): 4.19     MA(20): 4.33
MA(100): 3.95     MA(250): 4.27
MACD: MACD(12,26): -0.01     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 6.91     %D(3): 11.50
RSI: RSI(14): 42.04
52-week: High: 5.61  Low: 2.85  Change(%): -26.0
Average Vol(K): 3-Month: 102974  10-Days: 163904

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BDSI has closed above bottom band by 9.8%. Bollinger Bands are 4.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 15 Jan 2021
BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting - GlobeNewswire

Wed, 11 Nov 2020
BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18 - GlobeNewswire

Sat, 07 Nov 2020
BioDelivery Sciences International, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Yahoo Finance

Fri, 06 Nov 2020
Is BioDelivery Sciences International (NASDAQ:BDSI) Using Too Much Debt? - Yahoo Finance

Thu, 05 Nov 2020
BioDelivery Sciences Reports Strong Q3 2020 Results Nasdaq:BDSI - GlobeNewswire

Wed, 04 Nov 2020
BioDelivery Sciences Announces $25 Million Share Repurchase Program - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101
Shares Float (M) 82
% Held by Insiders 2.45
% Held by Institutions 73.76
Shares Short (K) 2,470
Shares Short P. Month (K) 3,080

Stock Financials

EPS 0.153
EPS Est This Year 0.120
EPS Est Next Year -0.640
Book Value (p.s.) 0.950
Profit Margin 10.15
Operating Margin 19.19
Return on Assets (ttm) 8.7
Return on Equity (ttm) 18.1
Qtrly Rev. Growth 30.1
Gross Profit (p.s.) 0.903
Sales Per Share 1.443
EBITDA (p.s.) 0.353
Qtrly Earnings Growth 2550.60
Operating Cash Flow (M) 31
Levered Free Cash Flow (M) 10

Stock Valuations

PE Ratio 26.60
PEG Ratio
Price to Book value 4.28
Price to Sales 2.82
Price to Cash Flow 13.32

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.